Summary
The number of people travelling to tropical or subtropical countries, whether for holidays or for business, is steadily increasing. Many of these travellers are at risk of acquiring an infectious disease. Protection against certain infectious diseases is possible by vaccination. Vaccinations required or recommended for adults are reviewed here. Progress in the refinement of available vaccines, as well as the development of new vaccines, is discussed.
Zusammenfassung
Immer mehr Menschen reisen zur Erholung oder beruflich in tropische und subtropische Länder. Bei vielen dieser Reisen ist mit einem Infektionsrisiko für bestimmte Krankheiten zu rechnen. Gegen einige Infektionskrankheiten kann man sich durch Impfungen schützen. In der folgenden Übersicht wird auf Impfungen bei Erwachsenen eingegangen, die anläßlich von Reisen in tropische und subtropische Regionen notwendig sind beziehungsweise empfohlen werden. Weiterentwicklungen von bereits vorhandenen sowie Entwicklungen von bislang nicht verfügbaren Impfstoffen werden diskutiert.
Article PDF
Similar content being viewed by others
References
Bockemühl, J. Reisediarrhoc. Dtsch. Ärztebl. 88 (1991) 1437–1440.
Pöhn, H. P., Zastrow, K. D., Großmann, R. Infektionskrankheiten: Epidemiologische Situation 1989 in der Bundesrepublik Deutschland. Bundesgesundhbl. 34 (1991) 199–202.
Pietsch, M. Lücken in der Impfimmunität der Deutschen Bevölkerung. Hyg. und Med. 16 (1991) 158–163.
Werner, G. T., Berdel, W. E., Frühwein, N., Ulm, K. Untersuchungen zur Tetanusimmunität der Münchner Bevölkerung. Münch. Med. Wochenschr. 129 (1987) 157–159.
Korger, G., Quast, U., Decnert, G. Tetanusimpfung — Verträglichkeit und Vermeidung von Nebenreaktionen. Klin. Wochenschr. 64 (1986) 767–775.
Halsey, N. A., Smith, M. H. D. Diphtheria. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geogrpahical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 860–867.
Korzenkova, M. P., Ivanov, V. A., Platonova, T. V., Doljikova, M. A. Routine screening forCorynebacterium diphtheriae. Lancet 338 (1991) 577–578.
Anonymous: Expanded programme on immunization. Outbreak of diphtheria. Wkly. Epidemiol. Rec. 66 (1991) 181–185.
Höfler, W., Heizmann, W., Höring, E., Junga, C., von Gaisberg, U., Kusch, G., Weidner, F. Drei Fälle von Hautdiphtherie bei Afrikareisenden. Dtsch. Ärztebl. 86 (1989) 221–223.
Melnick, J. L. Poliomyelitis. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 559–576.
Anonymous: Expanded programme of immunization. Wkly. Epidemiol. Rec. 65 (1990) 34–35.
Sutter, R. W., Patriarca, P. A., Brogan, S., Malankar, P. G., Pallansch, M. A., Kew, O. M., Bass, A. G., Cocji, S. L., Alexander, J. P., Hall, D. B., Suleiman, A. J. M., Al-Ghassany, A. A. K., El-Bualy, M. S. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 338 (1991) 715–720.
Beale, A. J. Polio vaccines: time for a change in immunization policy. Lancet 335 (1990) 839–842.
Schwick, H. G. Poliomyelitis, in der Zeit von Landsteiner und heute. Wien. Klin. Wochenschr. 103 (1991) 136–140.
Minor, P. D., Macadam, A., Cammack, N., Dunn, G., Almond, J. W. Molecular biology and the control of viral vaccines. FEMS Microbiol. Immunol. 2 (1990) 207–213.
Flehmig, B., Heinricy, U., Pfister, M. Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers. Lancet 334 (1989) 1039–1041.
Chriske, H. W., Abdo, R., Rickrath, R., Braumann, S. Hepatitis-A-Infektionsgefährdung bei Kanal-und Klärwerksarbeiten. In:Zerlett, G., Chriske, H. W. (eds.): Arbeitsmedizin im Öffentlichen Dienst. Tagungsbericht 1990. Gentner Verlag, Stuttgart 1990, pp. 159–163.
Andre, F. E., Hepburn, A., D'Hondt, E. Inactivated candidate vaccines for hepatitis A. Prog. Med. Virol. 37 (1990) 72–95.
Salata, R. A., Olds, G. R. Infectious diseases in travellers and immigrants. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 228–242.
Butler, T. Typhoid fever. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 753–757.
Anonymous: Yellow fever in 1988. Wkly. Epidemiol. Rec. 65 (1990) 213–220.
Anonymous: Expanded programme on immunization. Part I. Wkly. Epidemiol. Rec. 67 (1992) 11–15.
Schwartz, B., Moore, P. S., Broome, C. V. Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2 (1989) (Suppl.) S118-S124.
Scheld, W. M. Meningococcal diseases. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 798–814.
Anonymous: Meningococcal meningitis in Africa. Wkly. Epidemiol. Rec. 65 (1990) 120–122.
Anonymous: Vaccination requirements. Pilgrimage to Mecca (Hajj). Wkly. Epidemiol. Rec. 66 (1991) 99.
Frasch, C. E. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2 (1989) (Suppl.) S134-S138.
Umenai, T., Krzysko, R., Bektimirov, T. A., Assaad, F. A. Japanese encephalitis: current worldwide status. Bull. World Health Organ. 63 (1985) 625–631.
Ruff, T. A., Eisen, D., Fuller, A., Kass, R. Adverse reactions to Japanese encephalitis vaccine. Lancet 338 (1991) 881–882.
Andersen, M. M., Ronne, T. Side effects with Japanese encephalitis vaccination. Lancet 337 (1991) 1044.
Denning, D. W., Kaneko, Y. Should travellers to Asia be vaccinated against Japanese encephalitis? Lancet i (1987) 853–854.
Warrel, D. A., Shope, R. E. Rabies. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 635–644.
Butler, T., Sack, D. Cholera. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 745–753.
Exner, M., Böllert, F. Hygienische Aspekte der Cholera unter besonderer Berücksichtigung der Epidemie in Südamerika. Bundesgesundhbl. 34 (1991) 401–414.
Anonymous: Vaccination requirements. Wkly. Epidemiol. Rec. 66 (1991) 56.
Tsen, Y. J., Chang, M. H., Hsu, H. Y., Lee, C. Y., Sung, J. L., Chen, D. S. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J. Med. Virol. 34 (1991) 96–99.
Ronish, R. H., Diniega, B. M., Kelley, P. W., Sjogren, M. H., Arday, D. R., Aronson, N. E., Hoke, C. H., Petruccelli, B. P. Immunogenicity achieved by the intradermal hepatitis B vaccination programme for US Army soldiers in Korea. Vaccine 9 (1991) 364–368.
Anonymous: Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B—United States, 1990–1991. MMWR 40 (1991) 569–572.
Halsey, N. A., Job, J. S. Measles. In:Warren, K. S., Mahmoud, A. A. F. (eds.): Tropical and geographical medicine. McGraw-Hill Information Service Co., New York 1990, pp. 607–619.
Anonymous: The measles epidemic. The problems, barriers, and recommendations. The National Vaccine Advisory Committee. JAMA 266 (1991) 1547–1552.
Campos Outcalt, D. Measles update. Am. Fam. Physician 42 (1990) 1274–1283.
Atkinson, W. L., Markowitz, L. E., Adams, N. C., Seastrom, G. R. Transmission of measles in medical settings—United States, 1985–1989. Am. J. Med. 91 (1991) 320.
LaForce, F. M. Adult immunizations: are they worth the trouble? J. Gen. Intern. Med. 5 (1990) (Suppl.) S57-S61.
Filice, G. A., Pomeroy, C. Preventing secondary infections among HIV-positive persons. Public Health Rep. 106 (1991) 503–517.
Weber, R., Lüthy, R. Sekundärprophylaxe bei HIV-Infektion. Ther. Umsch. 48 (1991) 258–263.
Opravil, M., Fierz, W., Matter, L., Blaser, J., Lüthy, R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin. Exp. Immunol. 84 (1991) 185–189.
Péret, R.: Biotechnologies et vaccinations. Actual Odontostomatol. Paris (1990) 663–674.
Peeters, C. C., Tenbergen-Meekes, A. M., Poolman, J. T., Beurret, M., Zegers, B. J., Rijkers, G. T. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect. Immun. 59 (1991) 3504–3510.
Robbins, J. B., Schneerson, R. Evaluating theHaemophilus influenzae type b conjugate vaccine PRP-D. N. Engl. J. Med. 323 (1990) 1415–1416.
Parke, J. C. Jr., Schneerson, R., Reimer, C., Black, C., Welfare, S., Bryla, D., Levi, L., Pavliakova, D., Cramton, T., Schulz, D., Cadoz, M., Robbins, J. B. Clinical and immunologic responses toHaemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7 and 18 months of age. J. Pediatr. 118 (1991) 184–190.
O'Callaghan, D., Charbit, A., Martineau, P., Leclerc, C., van der Werf, S., Nauciel, C., Hofnung, M. Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins. Res. Microbiol. 141 (1990) 963–969.
Shiraki, K., Hayakawa, Y., Mori, H., Namazue, J., Takamizawa, A., Yoshida, I., Yamanishi, K., Takahashi, M. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J. Gen. Virol. 72 (1991) 1393–1399.
Karayiannis, P., O'Rourke, S., McGarvey, M. J., Luther, S., Waters, J., Goldin, R., Thomas, H. C. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity. J. Gen. Virol. 72 (1991) 2167–2172.
Mao, J. S. Development of live, attenuated hepatitis A vaccine (H2-strain). Vaccine 8 (1990) 523–524.
Lewis, D. J., Novotny, P., Dougan, G., Griffin, G. E. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur. J. Immunol. 21 (1991) 2087–2094.
Rao, N. Protecting travelers from typhoid fever. Infect. Control. Hosp. Epidemiol. 12 (1991) 168–172.
Putnak, J. R., Schlesinger, J. J. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b. J. Gen. Virol. 71 (1990) 1697–1702.
Mason, P. W., Pincus, S., Fournier, M. J., Mason, T. L., Shope, R. E., Paoletti, E. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180 (1991) 294–305.
Yasui, K., Miyamoto, M., Kimura Kuroda, J., Yasuda, A., Matsuura, Y., Sato, T., Kojima, A., Kubonoya, H. Analysis of Japanese encephalitis (JE) virus genome and implications for recombinant JE vaccine. Southeast Asian J. Trop. Med. Public Health 21 (1990) 663–669.
Fu, Z. F., Dietzschold, B., Schumacher, C. L., Wunner, W. H., Ertl, H. C., Koprowski, H. Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. Proc. Natl. Acad. Sci. USA 88 (1991) 2001–2005.
Linhart, S. B., Blom, F. S., Dasch, G. J., Roberts, J. D., Engeman, R. M., Esposito, J. J., Shaddock, J. H., Baer, G. M. Formulation and evaluation of baits for oral rabies vaccination of raccoons (Procyon lotor). J. Wildl. Dis. 27 (1991) 21–33.
Bachmann, P., Bramwell, R. N., Fraser, S. J., Gilmore, D. A., Johnston, D. H., Lawson, K. F., MacInnes, C. D., Matejka, F. O., Miles, H. E., Pedde, M. A., Webster, W. A. Wild carnivore acceptance of baits for delivery of liquid rabies vaccine. J. Wildl. Dis. 26 (1990) 486–501.
Forrest, B. D., LaBrooy, J. T. In vivo evidence of immunological masking of theVibrio cholerae O antigen of a hybridSalmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans. Vaccine 9 (1991) 515–520.
Schodel, F., Will, H. Expression of hepatitis B virus antigens in attenuated salmonellae for oral immunization. Res. Microbiol. 141 (1990) 831–837.
Anonymous: Potential use of live viral and bacterial vectors for vaccines. WHO meeting, Geneva, 19–22 June, 1989. Vaccine 8 (1990) 425–437.
Francis, M. J. Peptide vaccines for viral diseases. Sci. Prog. 74 (1990) 115–130.
Etlinger, H. M., Renia, L., Matile, H., Manneberg, M., Mazier, D., Trzeciak, A., Gillessen, D. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide. Eur. J. Immunol. 21 (1991) 1505–1511.
Stürchler, D., Zimmer, G., Berger, R., Etlinger, H., Fernex, M., Matile, H., Just, M. Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks. Bull. World Health Organ. 68 (1990) 38–41.
Herrington, D. A., Clyde, D. F., Davis, J. R., Baqar, S., Murphy, J. R., Cortese, J. F., Bank, R. S., Nardin, E., DiJohn, D., Nussenzweig, R. S., Nussenzweig, V., Torres, J. R., Murillo, J., Cortesia, M., Stürchler, D. Human studies with synthetic peptide sporozoite vaccine (NAN)3-TT and immunization with irradiated sporozoites. Bull. World Health Organ. 68 (1990) 33–37.
Dietzschold, B., Ertl, H. C. New developments in the pre- and post-exposure treatment of rabies. Crit. Rev. Immunol. 10 (1991) 427–439.
Liebermann, H., Holl, U., Reimann, I., Nockler, A., Schafer, D., Thalmann, G., Dolling, R. Synthetic peptides against foot-and-mouth disease — immunization with VP1-peptides of type O1-Kaufbeuren. Arch. Exp. Veterinärmed. 44 (1990) 883–890.
Del Val, M., Schlicht, H. J., Volkmer, H., Messerle, M., Reddehase, M. J., Koszinowski, U. H. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65 (1991) 3641–3646.
Sjolander, A., Lovgren, K., Stahl, S., Aslund, L., Hansson, M., Nygren, P. A., Larsson, M., Hagstedt, M., Wahlin, B., Berzins, K., Uhlén, M., Morein, B., Perlmann, P. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of thePlasmodium falciparum antigen Pf155/RESA. Vaccine 9 (1991) 443–450.
Hoglund, S., Akerblom, L., Ozel, M., Villacres, M., Eriksson, M., Gelderblom, H. R., Arthur, L., Morein, B. Characterization of immunostimulating complexes (ISCOMS) of HIV-1. Viral Immunol. 3 (1990) 195–206.
Morein, B. The iscom: an immunostimulating system. Immunol. Lett. 25 (1990) 281–283.
Zhou, E. M., Dreesman, G. R., Kennedy, R. C. Anti-idiotypic antibodies: a new generation of vaccines against infectious agents. Microbiol. Sci. 4 (1987) 36–40.
Robins, R. A., Denton, G. W., Hardcastle, J. D., Austin, E. B., Baldwin, R. W., Durrant, L. G. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res. 51 (1991) 5425–5429.
Pohl, C., Sieber, M., Diehl, V., Pfreundschuh, M. Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti- idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3. Anticancer Res. 11 (1991) 1115–1124.
Chanh, T. C., Siwak, E. B., Hewetson, J. F. Anti-idiotype-based vaccines against biological toxins. Toxicol. Appl. Pharmacol. 108 (1991) 183–193.
Guiguemde, T. R., Stürchler, D., Ouedraogo, J. B., Drabo, M., Etlinger, H., Douchet, C., Gbary, A. R., Haller, L., Kambou, S., Fernex, M. Vaccination contre le paludisme: premier essai vacc un vaccin antisporozoite, le (NANP)3-TT (RO 40-2361) en Afrique (Bobo-Dioulasso, Burkina-Faso). Bull. Soc. Pathol. Exot. Filiales 83 (1990) 217–227.
Edelman, R., Levine, M. M. Enteric vaccines. Md. Med. J. 40 (1991) 199–203.
Levine, M. M. Vaccines and milk immunoglobulin concentrates for prevention of infectious diarrhea. J. Pediatr. 118 (1991) (Suppl.) S129-S136.
Holmgren, J., Svennerholm, A. M. New vaccines against bacterial enteric infections. Scand. J. Infect. Dis. 70 (1990) (Suppl.) 149–156.
Sack, D. A., Freij, L., Holmgren, J. Swedish Agency for Research Cooperation with Developing Countries. Prospects for public health benefits in developing countries from new vaccines against enteric infections. J. Infect. Dis. 163 (1991) 503–506.
Anonymous: Dengue haemorrhagic fever (DHF). Wkly. Epidemiol. Rec. 65 (1990) 13–15.
Kurth, R., Binninger, D., Ennen, J., Denner, J., Hartung, S., Norley, S. The quest for an AIDS vaccine: the state of the art and current challenges. AIDS Res. Hum. Retroviruses 7 (1991) 425–433.
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr.H.-J. Gerth on the occasion of his 65th birthday.
Rights and permissions
About this article
Cite this article
Döller, P.C. Vaccination of adults against travel-related infectious diseases, and new developments in vaccines. Infection 21, 1–17 (1993). https://doi.org/10.1007/BF01739302
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01739302